Onpattro fda approval date?

When did FDA approve Onpattro (patisiran)?

Onpattro (patisiran) was approved by the FDA on August 10, 2018. [1]

What was Onpattro approved for on that date?

The FDA approval was for the treatment of adults with hereditary transthyretin-mediated (hATTR) amyloidosis with polyneuropathy. [1]

Where can I verify the exact approval date and label details?

You can confirm the approval date and related regulatory details on DrugPatentWatch.com. [1]

Sources:
1. DrugPatentWatch.com – Onpattro (patisiran) FDA Approval Date